Literature DB >> 25248940

Elevated serum levels of TNF-α, IL-6 and IL-18 in chronic schizophrenic patients.

Yayan Luo1, Hongbo He1, Minling Zhang1, Xini Huang1, Jie Zhang1, Yanling Zhou1, Xianguo Liu2, Ni Fan3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25248940     DOI： 10.1016/j.schres.2014.09.015

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  Transcription of PIK3CD in human brain and schizophrenia: regulation by proinflammatory cytokines.

Authors:  Veronica L Hood; Ralph Berger; Robert Freedman; Amanda J Law
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

2.  Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.

Authors:  Ni Fan; Yayan Luo; Ke Xu; Minling Zhang; Xiaoyin Ke; Xini Huang; Yi Ding; Daping Wang; Yuping Ning; Xuefeng Deng; Hongbo He
Journal:  Schizophr Res       Date:  2015-11-14       Impact factor: 4.939

3.  Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia.

Authors:  Saeed Kadasah; Misbahul Arfin; Sadaf Rizvi; Mohammed Al-Asmari; Abdulrahman Al-Asmari
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-12       Impact factor: 2.570

4.  Serum level of high sensitive C-reactive protein and IL - 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study.

Authors:  Feyissa Challa; Daniel Seifu; Meron Sileshi; Tigist Getahun; Zeleke Geto; Desta Kassa; Melkam Alemayehu; Miraf Mesfin; Abebaw Fekadu; Yimtubezinash Woldeamanuel
Journal:  BMC Psychiatry       Date:  2021-08-31       Impact factor: 3.630

5.  Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3.

Authors:  Shinnosuke Yamada; Norimichi Itoh; Taku Nagai; Tsuyoshi Nakai; Daisuke Ibi; Akira Nakajima; Toshitaka Nabeshima; Kiyofumi Yamada
Journal:  J Neuroinflammation       Date:  2018-10-22       Impact factor: 8.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.